¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 1ÀÏ : 2021-04-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 1ÀÏ : 2021-04-01
±³À°ÀÏÀÚ : 2021-04-01
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 1ÀÏ      
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : À±ÁöÇý
¿¬¶ôó : 02-566-6031  
À̸ÞÀÏ : hematology@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í ´ëÇÑÇ÷¾×ÇÐȸ ȸ¿ø £Ü50,000, Æç·Î¿ì/°£È£»ç/¿¬±¸¿ø £Ü30,000Çлý/Àü°øÀÇ £Ü20,000, ºñȸ¿ø £Ü150,000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 09:00~09:30 Contemporary Treatment of Pediatric Ph+ ALL  Kirk Schultz(University of British Columbia Canada) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 09:30~10:00 Current Treatment Approaches to Newly Diagnosed Adult ALL  Daniel Joseph DeAngelo(Dana Farber Cancer Institute USA) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 10:00~10:30 Results of High Risk and Novel Subtypes of Pediatric ALL in Japan  Katsuyoshi Koh(Saitama Children's Medical Center Japan) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 10:30~11:15 Clonal Hematopoiesis and the Origin of Hematologic Malignancies  Benjamin Ebert(Dana-Farber Cancer Institute USA) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 11:30~12:10 New Treatment Option for FLT3 mutant AML  Alexander Edward Perl(University of Pennsylvania USA) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 12:55~13:25 From Korean Perspective  µµ¿µ·Ï(°è¸íÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 13:25~13:55 From Chinese Perspective  Qian Jiang(Peking University China) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 13:55~14:25 From Japanese Perspective  Shinya Kimura(Saga University Japan) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 14:40~15:00 Single Cell RNA Sequencing Reveals Tranional Programs Associated with Myeloma Progression  ÀÌÇý¿Á(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 15:00~15:20 ulti-Omics Analysis and Modeling of DNA Methylation in Cancer  ±è¼±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 15:20~15:45 Clinical Application of Next-Generation Sequencing in Acute Myeloid Leukemia  ¾ÈÀç¼÷(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 15:45~16:10 Challenges in the Introduction of Next-Generation Sequencing for Diagnostics of Hematologic Malignancies  À̽ÂÅÂ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 16:25~16:55 Novel Strategies to Overcome Relapsed/Refractory Multiple Myeloma  Suzanne Trudel(University of Toronto Canada) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 16:55~17:25 MRD Negativity - The Foremost Important Goal of Myeloma Treatment?  Bruno Paiva(University of Navarra Spain) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 17:25~17:50 Primary Amyloidosis  ±è±âÇö(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 1ÀÏ : 2021-04-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 1Çбâ À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ - ±¸°­ÀÛ¿­ÁõÈıº(Burning mouth syndrome) : 2021-04-01
´ÙÀ½±Û (¿Â¶óÀÎ) 2021 ´ëÇÑÅëÁõ¿¬±¸ÇÐȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ : 2021-03-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20454 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-05-18 0 67 2024-04-17
20453 ¼­¿ï 2024³â ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¦14ȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 52 2024-04-17
20452 Àü³² 2024³â Á¦74Â÷ ´ëÇÑÇÙÀÇÇÐȸ ÇÙÀÇÇÐ ¿¬¼ö±³À° : 2024-05-18 0 26 2024-04-17
20451 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ »ó¹Ý±â ÀÓ»óÁø·áÁöħ ±³À°¿öÅ©¼ó - ¡¸ÀÓ»óÁø·áÁöħÀÇ °³¹ß¡¹ ÀÌÇØÇϱâ : 2024-05-18 0 61 2024-04-17
20450 ´ëÀü ´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦60ȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-18 0 35 2024-04-17
20449 ¼­¿ï Á¦12Â÷ ´ëÇѼչßÅéÇÐȸ Nail forum : 2024-05-18 0 45 2024-04-17
20448 Àü³² 2024³â Á¦62Â÷ ´ëÇÑÇÙÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-17 0 34 2024-04-17
20447 ´ëÀü ´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦60ȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-17 0 31 2024-04-17
20446 °­¿ø °³¿ø°¡¿¡¼­ Á¢ÇÏ´Â ¿©·¯ÁúȯÀÇ ´ëó¹ý : 2024-05-14 0 35 2024-04-17
20445 ¼­¿ï 2024 ¾Æ½Ã¾Æ±¹Á¦¹Ì¿ëÀÇÇÐÆ÷·³(2ÀÏÂ÷) : 2024-05-12 0 77 2024-04-17
20444 ¼­¿ï Á¦3ȸ °³¿øÀÇ¿Í ÃʽÉÀÚ°¡ ÇÔ²²ÇÏ´Â ´ëÇÑ»êºÎÀΰú·Îº¿¼ö¼úÇÐȸ Çмú´ëȸ : 2024-05-12 0 41 2024-04-17
20443 ¼­¿ï 2024 ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-12 0 35 2024-04-17
20442 ¼­¿ï Á¦ 3Â÷ ÁßȯÀÚ½ÅÀåÇבּ¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-11 0 66 2024-04-17
20441 ´ë±¸ 2024³â ´ëÇÑ°í°üÀýÇÐȸ ±¹Á¦Çмú´ëȸ(ICKHS 2024) (3ÀÏÂ÷) : 2024-05-11 0 50 2024-04-17
20440 ¼­¿ï 2024 ¾Æ½Ã¾Æ±¹Á¦¹Ì¿ëÀÇÇÐÆ÷·³(1ÀÏÂ÷) : 2024-05-11 0 72 2024-04-17
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷